Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-03

Clinical Trial Update: Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus [Phase 2]

View source ↗

Summary

Clinical trial update shows a Phase 2 evaluation of a new covered metal stent for malignant esophageal lesions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Esophageal Cancer | Phase 2 | Status: WITHDRAWN